CG
CTSO icon

Cutler Group’s Cytosorbents Corp CTSO Stock Holding History

Cutler Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-512
Closed -$1K – 4996
2022
Q2 		$1K Hold
512
– – ﹤0.01% 4532
2022
Q1 		$1K Buy
+512
New +$1.83K ﹤0.01% 4921
2020
Q3 		– Sell
-600
Closed -$5K – 4751
2020
Q2 		$5K Buy
+600
New +$5.51K ﹤0.01% 3277
2016
Q4 		– Sell
-1,200
Closed -$6.57K – 6618
2016
Q3 		$7K Buy
+1,200
New +$6.24K ﹤0.01% 4574
2016
Q1 		– Sell
-400
Closed -$1.74K – 6585
2015
Q4 		$2K Buy
+400
New +$2.72K ﹤0.01% 5519

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Cutler Group's CTSO Position: Q3 2022 in Review

Cutler Group sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 512 shares — an estimated $1K sold.

Cutler Group first reported a position in CTSO in Q4 2015 and held it in 5 quarters. The position peaked at $7K in Q3 2016. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Cutler Group reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 512 Cytosorbents Corp shares in Q3 2022, an estimated $1K.
  • Cutler Group first reported a position in Cytosorbents Corp in Q4 2015 and held it in 5 quarters.
  • Cutler Group's Cytosorbents Corp position peaked at $7K in Q3 2016.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.